Children and adolescents in low- and middle-income countries living with HIV showed a reduced viral load after treatment with ...
A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV.
In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...
One-third of children with HIV who received very early ART had no detectable virus in their body for at least 12 weeks after stopping treatment, according to study findings. It was another sign that ...
HIV infections are often recognized and treated too late in Europe, a study revealed on Thursday, with 54% of diagnoses in 2024 being made too late for optimal treatment. The joint report from the ...
FINDING COULD CHANGE TREATMENTS. MINDY. DEB, 54. NEWBORNS FROM AROUND THE WORLD RECEIVED ANTIRETROVIRAL THERAPY WITHIN 48 HOURS AFTER THEY WERE BORN, USUALLY, DOCTORS WAIT WEEKS OR EVEN MONTHS AFTER ...
ViiV Healthcare’s long-acting Cabenuva for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges: London, UK Friday, February 20 ...
HIV has come a long way since the first documented cases emerged in the U.S. over 40 years ago. Today, living well with HIV is possible with proper care and medication. Yet, harmful myths about HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results